Search research articles
Contact Us
Filters
Showing results (571-580 of 607) with videos related to
Page
of 61
Sort By:
European Urology Focus
|
July 30, 2017
Programmed Death-ligand 1 Expression in Upper Tract Urothelial Carcinoma
Stephanie L Skala, Tzu-Ying Liu, Aaron M Udager, et al.
Msphere
|
July 3, 2020
Increasing Temperature and Relative Humidity Accelerates Inactivation of SARS-CoV-2 on Surfaces
Jennifer Biryukov, Jeremy A Boydston, Rebecca A Dunning, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 25, 2020
Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma
Christopher M Wright, Michael J LaRiviere, Jonathan A Baron, et al.
Plos One
|
October 11, 2012
qpure: A tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profiles
Sarah Song, Katia Nones, David Miller, et al.
Regulatory Toxicology and Pharmacology : RTP
|
October 31, 2021
Opportunities and challenges related to saturation of toxicokinetic processes: Implications for risk assessment
Yu-Mei Tan, Hugh A Barton, Alan Boobis, et al.
The Journal of Nutrition
|
March 31, 2004
Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize
Walter F O Marasas, Ronald T Riley, Katherine A Hendricks, et al.
Current Environmental Health Reports
|
August 2, 2015
MDI Biological Laboratory Arsenic Summit: Approaches to Limiting Human Exposure to Arsenic
Bruce A Stanton, Kathleen Caldwell, Clare Bates Congdon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2016
The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical Models
Sen Zhang, Rana Anjum, Rachel Squillace, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 25, 2022
A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for Locally Advanced Prostate Cancer
Liat Hammer, Ralph Jiang, Jason Hearn, et al.
Journal of Medicinal Chemistry
|
November 25, 2024
Novel Macrocyclic NLRP3 Inhibitors
Stefanie Mesch, Jonathan Shannon, David Miller, et al.
Page
of 61
Search research articles
Search
Showing results (571-580 of 607) with videos related to
Sort By:
Page
of 61
European Urology Focus
|
July 30, 2017
Programmed Death-ligand 1 Expression in Upper Tract Urothelial Carcinoma
Stephanie L Skala, Tzu-Ying Liu, Aaron M Udager, et al.
Msphere
|
July 3, 2020
Increasing Temperature and Relative Humidity Accelerates Inactivation of SARS-CoV-2 on Surfaces
Jennifer Biryukov, Jeremy A Boydston, Rebecca A Dunning, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 25, 2020
Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma
Christopher M Wright, Michael J LaRiviere, Jonathan A Baron, et al.
Plos One
|
October 11, 2012
qpure: A tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profiles
Sarah Song, Katia Nones, David Miller, et al.
Regulatory Toxicology and Pharmacology : RTP
|
October 31, 2021
Opportunities and challenges related to saturation of toxicokinetic processes: Implications for risk assessment
Yu-Mei Tan, Hugh A Barton, Alan Boobis, et al.
The Journal of Nutrition
|
March 31, 2004
Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize
Walter F O Marasas, Ronald T Riley, Katherine A Hendricks, et al.
Current Environmental Health Reports
|
August 2, 2015
MDI Biological Laboratory Arsenic Summit: Approaches to Limiting Human Exposure to Arsenic
Bruce A Stanton, Kathleen Caldwell, Clare Bates Congdon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2016
The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical Models
Sen Zhang, Rana Anjum, Rachel Squillace, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 25, 2022
A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for Locally Advanced Prostate Cancer
Liat Hammer, Ralph Jiang, Jason Hearn, et al.
Journal of Medicinal Chemistry
|
November 25, 2024
Novel Macrocyclic NLRP3 Inhibitors
Stefanie Mesch, Jonathan Shannon, David Miller, et al.
Page
of 61